Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.082 AUD | 0.00% | -9.89% | -39.26% |
Apr. 24 | Rhythm Biosciences Appoints CEO; Shares Down 3% | MT |
Mar. 21 | Rhythm Biosciences Receives AU$2.5 Million Under Rights Issue; Shares Up 3% | MT |
Sales 2022 | 2.43 3.69 | Sales 2023 | 3.1 4.71 | Capitalization | 90.11M 137M |
---|---|---|---|---|---|
Net income 2022 | -8M -12.17M | Net income 2023 | -8M -12.17M | EV / Sales 2022 | 98,363,837 x |
Net cash position 2022 | 7.43M 11.3M | Net cash position 2023 | 4.08M 6.21M | EV / Sales 2023 | 27,789,011 x |
P/E ratio 2022 |
-27.4
x | P/E ratio 2023 |
-10.8
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 59.75% |
1 week | -9.89% | ||
Current month | -13.68% | ||
1 month | -14.58% | ||
3 months | -34.40% | ||
6 months | -53.14% | ||
Current year | -39.26% |
Managers | Title | Age | Since |
---|---|---|---|
Darren Moulton
COO | Chief Operating Officer | - | - |
Trevor Lockett
BRD | Director/Board Member | - | 17-05-31 |
Guy Carisbrooke
AUD | Comptroller/Controller/Auditor | - | 23-09-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Otto Buttula
CHM | Chairman | - | 19-10-27 |
Louis Panaccio
BRD | Director/Board Member | 67 | 17-07-31 |
Susan MacLeman
BRD | Director/Board Member | - | 23-01-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 0.082 | 0.00% | 22 434 |
24-05-02 | 0.082 | -1.20% | 68,404 |
24-05-01 | 0.083 | +1.22% | 18,450 |
24-04-30 | 0.082 | +1.23% | 17,635 |
24-04-29 | 0.081 | -3.57% | 450,920 |
Delayed Quote Australian S.E., May 03, 2024 at 01:05 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-39.26% | 13.19M | |
-18.16% | 11.13B | |
+58.43% | 3.6B | |
-31.31% | 2.26B | |
-14.31% | 2.16B | |
-26.61% | 1.54B | |
+34.35% | 1.17B | |
-3.28% | 744M | |
-22.75% | 482M | |
-40.20% | 432M |
- Stock Market
- Equities
- RHY Stock